Cargando…

ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)

Devil Facial Tumour 1 (DFT1) is one of two transmissible neoplasms of Tasmanian devils (Sarcophilus harrisii) predominantly affecting their facial regions. DFT1’s cellular origin is that of Schwann cell lineage where lesions are evident macroscopically late in the disease. Conversely, the pre-clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Dane A., Kunde, Dale A., Taylor, Robyn L., Pyecroft, Stephen B., Sohal, Sukhwinder Singh, Snow, Elizabeth T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462353/ https://www.ncbi.nlm.nih.gov/pubmed/28591206 http://dx.doi.org/10.1371/journal.pone.0177919

Ejemplares similares

Anthropogenic selection enhances cancer evolution in Tasmanian devil tumours
por: Ujvari, Beata, et al.
Publicado: (2014)

Identification of candidate genes for devil facial tumour disease tumourigenesis
por: Taylor, Robyn L., et al.
Publicado: (2017)

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
por: Phalen, David N., et al.
Publicado: (2013)

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
por: Kosack, Lindsay, et al.
Publicado: (2019)

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
por: Tovar, Cesar, et al.
Publicado: (2017)

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils
por: Pye, Ruth, et al.
Publicado: (2016)

The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer
por: Caldwell, Alison, et al.
Publicado: (2018)

Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells
por: Petrohilos, Cleopatra, et al.
Publicado: (2023)

Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
por: Deakin, Janine E., et al.
Publicado: (2012)

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease
por: Lane, Amanda, et al.
Publicado: (2012)

Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes
por: Ingles, Emory D., et al.
Publicado: (2015)

Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
por: Hamede, Rodrigo K., et al.
Publicado: (2017)

Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease
por: Espejo, Camila, et al.
Publicado: (2021)

Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
por: Tovar, Cesar, et al.
Publicado: (2018)

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
por: Patchett, Amanda L., et al.
Publicado: (2016)

To Lose Both Would Look Like Carelessness: Tasmanian Devil Facial Tumour Disease
por: McCallum, Hamish, et al.
Publicado: (2006)

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases
por: Kwon, Young Mi, et al.
Publicado: (2018)

Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells
por: Fernandez-Rojo, Manuel A., et al.
Publicado: (2018)

Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
por: Bell, Olivia, et al.
Publicado: (2021)

Comparative Cytogenetic Mapping and Telomere Analysis Provide Evolutionary Predictions for Devil Facial Tumour 2
por: Ingles, Emory D., et al.
Publicado: (2020)

The Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils
por: Stammnitz, Maximilian R., et al.
Publicado: (2018)

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association
por: Wright, Belinda, et al.
Publicado: (2017)

Devil Facial Tumour Disease (DFTD): Using Genetics and Genomics to Investigate Infectious Disease in an Endangered Marsupial
por: Bender, Hannah S.
Publicado: (2010)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD)
por: Hussey, Kathryn, et al.
Publicado: (2022)

Disruption of Metapopulation Structure Reduces Tasmanian Devil Facial Tumour Disease Spread at the Expense of Abundance and Genetic Diversity
por: Durrant, Rowan, et al.
Publicado: (2021)

Correction: Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
Publicado: (2014)

Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells
por: Pinfold, Terry L., et al.
Publicado: (2014)

How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013)

The devil /
por: Molnár, Ferenc, 1878-1952
Publicado: (1908)

Shout at the devil /
por: Smith, Wilbur A.
Publicado: (1956)

The devil's in the details
por: Petsko, Gregory A
Publicado: (2010)

The devil is in the details: Genomics of transmissible cancers in Tasmanian devils
por: Storfer, Andrew, et al.
Publicado: (2018)

The devils = (The possessed) /
por: Dostoyevsky, Fyodor, 1821-1881

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014)

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release
por: Pye, Ruth, et al.
Publicado: (2018)

Devil Driving. Panchoa Devils—Classed as "Silent" and "Crying"
por: Bagchi, K. P.
Publicado: (1914)

Sympathy for the devil: a conservation strategy for devil and manta rays
por: Lawson, Julia M., et al.
Publicado: (2017)

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells
por: Ong, Chrissie E. B., et al.
Publicado: (2019)

HMGB1, angel or devil, in ischemic stroke
por: Gao, Bin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fkm3mlpu7aun0e4o6htuq14oju